FDA Will Likely Stay Without a Confirmed Commissioner into November as Senate Panel Holds Off on Overton Vote

No Senate committee vote on FDA nominee Heidi Overton is expected before the midterms, leaving the agency under acting leadership through fall.

Have A Referral?